Episurf Medical AB (publ) (EPIS-B) - Total Assets

Latest as of December 2025: Skr59.80 Million SEK ≈ $6.44 Million USD

Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) holds total assets worth Skr59.80 Million SEK (≈ $6.44 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Episurf Medical AB (publ) - Total Assets Trend (2009–2025)

This chart illustrates how Episurf Medical AB (publ)'s total assets have evolved over time, based on quarterly financial data. Also see EPIS-B market cap for the company's overall valuation and market capitalisation.

Episurf Medical AB (publ) - Asset Composition Analysis

Current Asset Composition (December 2025)

Episurf Medical AB (publ)'s total assets of Skr59.80 Million consist of 29.6% current assets and 70.4% non-current assets. Review EPIS-B total debt and obligations to assess the company's total debt and financial obligations.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr0.00 11.9%
Accounts Receivable Skr5.50 Million 9.2%
Inventory Skr3.00 Million 5.0%
Property, Plant & Equipment Skr5.10 Million 8.5%
Intangible Assets Skr37.10 Million 62.0%
Goodwill Skr0.00 0.0%

Asset Composition Trend (2009–2025)

This chart illustrates how Episurf Medical AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Episurf Medical AB (publ) for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Episurf Medical AB (publ)'s current assets represent 29.6% of total assets in 2025, a decrease from 40.3% in 2009.
  • Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 24.5% in 2009.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 15.0% in 2009.
  • Asset Diversification: The largest asset category is intangible assets at 62.0% of total assets.

Episurf Medical AB (publ) Competitors by Total Assets

Key competitors of Episurf Medical AB (publ) based on total assets are shown below.

Company Country Total Assets
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
China CN¥16.89 Billion
Jafron Biomedical Co Ltd
SHE:300529
China CN¥5.20 Billion
Stratec SE
XETRA:SBS
Germany €408.98 Million
Shinhung
KO:004080
Korea ₩153.50 Billion
DRTECH Corporation
KQ:214680
Korea ₩235.84 Billion
Novacyt
PA:ALNOV
France €40.28 Million
Diagnostic Medical Systems SA
PA:ALDMS
France €62.52 Million

Episurf Medical AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.70 4.29 10.95
Quick Ratio 1.41 4.06 10.81
Cash Ratio 0.00 0.00 0.00
Working Capital Skr7.30 Million Skr45.80 Million Skr130.30 Million

Episurf Medical AB (publ) - Advanced Valuation Insights

This section examines the relationship between Episurf Medical AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.36
Latest Market Cap to Assets Ratio 0.24
Asset Growth Rate (YoY) -38.9%
Total Assets Skr59.80 Million
Market Capitalization $14.37 Million USD

Valuation Analysis

Below Book Valuation: The market values Episurf Medical AB (publ)'s assets below their book value (0.24x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Episurf Medical AB (publ)'s assets decreased by 38.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Episurf Medical AB (publ) (2009–2025)

The table below shows the annual total assets of Episurf Medical AB (publ) from 2009 to 2025.

Year Total Assets Change
2025-12-31 Skr59.80 Million
≈ $6.44 Million
-38.85%
2024-12-31 Skr97.80 Million
≈ $10.52 Million
-6.23%
2023-12-31 Skr104.30 Million
≈ $11.22 Million
-47.11%
2022-12-31 Skr197.20 Million
≈ $21.22 Million
-27.12%
2021-12-31 Skr270.60 Million
≈ $29.12 Million
+45.95%
2020-12-31 Skr185.40 Million
≈ $19.95 Million
+221.88%
2019-12-31 Skr57.60 Million
≈ $6.20 Million
+5.11%
2018-12-31 Skr54.80 Million
≈ $5.90 Million
-41.26%
2017-12-31 Skr93.29 Million
≈ $10.04 Million
+54.69%
2016-12-31 Skr60.30 Million
≈ $6.49 Million
-48.98%
2015-12-31 Skr118.20 Million
≈ $12.72 Million
+173.37%
2014-12-31 Skr43.24 Million
≈ $4.65 Million
-43.42%
2013-12-31 Skr76.42 Million
≈ $8.22 Million
+173.80%
2012-12-31 Skr27.91 Million
≈ $3.00 Million
-44.78%
2011-12-31 Skr50.55 Million
≈ $5.44 Million
+348.38%
2010-12-31 Skr11.27 Million
≈ $1.21 Million
+835.53%
2009-12-31 Skr1.20 Million
≈ $129.67K
--

About Episurf Medical AB (publ)

ST:EPIS-B Sweden Medical Devices
Market Cap
$14.37 Million
Skr133.57 Million SEK
Market Cap Rank
#26197 Global
#539 in Sweden
Share Price
Skr0.08
Change (1 day)
+1.90%
52-Week Range
Skr0.03 - Skr0.20
All Time High
Skr22.30
About

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more